Nonenzymatic glycosylation and the pathogenesis of diabetic complications.
about
Sarcoidosis and pain caused by small-fiber neuropathyCardiovascular Risk Factors for Alzheimer's DiseaseThe principal site of glycation of human complement factor BFructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytesImmunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patientsDietary interventions to extend life span and health span based on calorie restrictionAltered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamineMolecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targetsAdvanced glycation end products play adverse proinflammatory activities in osteoporosisAdvanced Glycation End Product Recognition by the Receptor for AGEsAdvanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)Role of the specifically targeted lysine residues in the glycation dependent loss of chaperone activity of alpha A- and alpha B-crystallinsAGEs in human lens capsule promote the TGFβ2-mediated EMT of lens epithelial cells: implications for age-associated fibrosisCommercial processed soy-based food product contains glycated and glycoxidated lunasin proteoformsPresence and Risk Factors for Glaucoma in Patients with Diabetes.The sour side of neurodegenerative disorders: the effects of protein glycation.Biomechanical properties of red blood cells in health and disease towards microfluidics.Identification of a pathway for the utilization of the Amadori product fructoselysine in Escherichia coli.Comprehensive analysis of glycated human serum albumin tryptic peptides by off-line liquid chromatography followed by MALDI analysis on a time-of-flight/curved field reflectron tandem mass spectrometer.Matrix-assisted laser desorption/ionization mass spectrometry, enzymatic digestion, and molecular modeling in the study of nonenzymatic glycation of IgG.Ascorbic acid supplementation restores defective leukocyte-endothelial interaction in alloxan-diabetic rats.Diabetes and mass spectrometry.Temporary effects of circulating Amadori products on glomerular filtration properties in the normal mouse.Direct evaluation of glycated and glyco-oxidized globins by matrix-assisted laser desorption/ionization mass spectrometry.Influence of glycosylation on the drug binding of human serum albumin.Diabetic macular edema: classification, medical and laser therapy.Current and future pharmacological intervention for diabetic retinopathy.Off-line liquid chromatography-MALDI by with various matrices and tandem mass spectrometry for analysis of glycated human serum albumin tryptic peptides.The effects of diabetes and aminoguanidine treatment on endothelial function in a primate model of type 1 diabetes.Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy.The Impact of Microbiota-Gut-Brain Axis on Diabetic Cognition Impairment.Dietary Metabolites and Chronic Kidney Disease.Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease.Fatty diabetic lung: altered alveolar structure and surfactant protein expressionAdvanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function.Resistance to axonal degeneration after nerve compression in experimental diabetes.The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes.A previously undescribed chemical link between smoking and metabolic diseaseAdvanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle.
P2860
Q21296687-B9B0FD1B-23A2-49FA-AB26-870E3A10FC2CQ22242643-F92D7F73-441A-48E5-973D-85D863F2DEA0Q24529553-190CC81F-B3E9-4493-84CF-6A6F8BCE5978Q24534263-931C2623-E8DD-43A9-88FF-F73289C3D5E3Q24561776-BC224683-7477-407B-9E36-7BACC034C83FQ24595003-F109699C-3FA7-45A6-B46C-0A7EDB2C7DB4Q26858946-332C519B-9DF1-4BD4-B597-BCA4E109F77BQ27014620-240F94F5-BD0D-4757-8DDA-098409325A54Q27024641-801CBCD6-1FE0-47A3-8D5A-0EC1C85766D6Q27667822-A15053B1-E4CF-442D-A961-24FAD59C61F7Q28366662-D2F01B1D-2863-4DF4-8E17-BD93BD592480Q28583058-50AF374B-8BA0-40A7-8C5A-9CE3265AFFAEQ28833644-1A2C85C5-F252-46CB-A998-9C5BAE162290Q28834062-B3F3B025-EDCC-4C46-95D0-E1545F149ED9Q30244246-4688313A-25E2-4F32-9738-89493EDF4336Q30386079-770EE1C5-1823-4DCA-B738-E40A56E0909BQ30402763-0C68BEB7-F046-41EE-BFDC-BA3D32637608Q30708333-629F80CE-6950-4E9C-A77D-754C3D13B4A9Q30822688-42DAF791-3531-42C0-AD15-40189E21D477Q30841683-AB52FC1E-4728-4B65-92FE-57ED468598E3Q30887324-9054709C-7088-4FC8-B2DA-C4D8E8F5DBEDQ30986952-D18289C9-1EF1-45FA-8CB8-D77480CF4039Q31767127-C5C6A50F-0690-4742-A62E-5E48E3C99AEEQ31919260-03120C80-DD1B-465F-8D5F-C82D44ED931DQ32053309-B9DB01B2-B252-4A72-A897-9DFAF13C0C87Q33208471-1B9A503A-20B2-47F7-BBC8-ECEB5D8F4F73Q33216425-2688F960-3D0B-46B0-83D6-F8249724FC87Q33278415-114B934C-547E-4BF3-BAA5-6D492F8881FCQ33334864-BC36FB7F-1F9F-45FC-8B8A-EF9DB1A2FB61Q33431322-EC7DC737-D031-4D64-8490-BAC162C2C125Q33607272-4295AE5E-089D-490E-81DA-ACAE0EF0511BQ33616732-E20B306F-69D4-4489-9681-56640BDC2D4AQ33633674-F226070E-F200-476F-965F-BA1C8A6A814FQ33728236-15D32535-323B-40C3-9717-AA46D7B1AD57Q33730962-68366D80-F384-4A15-8C26-BF04C8EC4072Q33845876-8EC1B4EF-7922-467E-B539-7902619C9792Q34083082-A9403323-2E0E-4010-B582-76AF8207F156Q34156512-8FD59F41-42FD-4B0C-9733-3999875F6330Q34180296-E4C92510-24F4-42AF-A7CC-E8455DD46162Q34258155-D1184ECF-5388-47AE-8298-17AA742D7575
P2860
Nonenzymatic glycosylation and the pathogenesis of diabetic complications.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Nonenzymatic glycosylation and the pathogenesis of diabetic complications.
@en
type
label
Nonenzymatic glycosylation and the pathogenesis of diabetic complications.
@en
prefLabel
Nonenzymatic glycosylation and the pathogenesis of diabetic complications.
@en
P2093
P1476
Nonenzymatic glycosylation and the pathogenesis of diabetic complications.
@en
P2093
P304
P356
10.7326/0003-4819-101-4-527
P407
P577
1984-10-01T00:00:00Z